Medistep Healthcare IPO Opens August 8: Key Details, Price & Growth Outlook

Investor attention turns to India’s bustling SME segment as Medistep Healthcare Limited prepares to launch its highly anticipated initial public offering. The Medistep Healthcare IPO will open for subscription on Friday, August 8, 2025, presenting a Rs 16.09 crore opportunity to own a stake in this rapidly expanding pharmaceutical and hygiene products company. With a price band set at Rs 43 per equity share and listing scheduled on the NSE SME platform for August 18, the offering marks a significant milestone for the company founded just two years ago.

Should You Consider the Medistep Healthcare IPO?

This IPO arrives amid strong financial momentum for Medistep. The company reported impressive growth in FY25, with revenue from operations surging 27% to Rs 4965.48 lakh, up from Rs 3907.19 lakh in FY24. Profitability followed suit: EBITDA climbed 23% to Rs 560 lakh, while Profit After Tax (PAT) increased nearly 25% to Rs 414.42 lakh. This performance underscores Medistep’s effective execution in manufacturing sanitary pads and energy powders, coupled with its extensive trading network for pharmaceuticals, nutraceuticals, intimate care products, and surgical supplies.

The offer comprises 37,44,000 equity shares at Rs 43 each. Investors must apply in lots of 3,000 shares, translating to a minimum investment of Rs 129,000. Allocation is structured with 17.79 lakh shares reserved for retail investors, 17.76 lakh for non-institutional investors, and 1.89 lakh for market makers. Fast Track Finsec Private Limited is managing the issue, with Cameo Corporate Services Limited as Registrar. Mr. Girdhari Lal Prajapati, Managing Director, emphasized the strategic intent: “The proceeds will support expansion, enhance our manufacturing capabilities, and strengthen our position in domestic and international markets. Our diversified portfolio meets rising global demand for health and hygiene solutions.

Business Model and Market Position

Medistep Healthcare has rapidly carved a niche since its 2023 inception, further solidified by acquiring M/s MG Pharma in 2024. Its hybrid model combines proprietary manufacturing (sanitary pads, energy powders) with a vast distribution network for third-party healthcare products. This dual approach leverages India’s growing hygiene awareness and expanding pharmaceutical market. The company emphasizes affordability and wide retail penetration, targeting value-conscious consumers across product categories. Their low-cost offerings in sanitary products, combined with the high-volume trading of pharmaceuticals and nutraceuticals, create a resilient revenue stream positioned for sustained growth as health expenditure rises nationwide.

Utilization of Proceeds and Expansion Plans

Medistep aims to deploy the IPO capital strategically:

• Capital Expenditure: Funding machinery purchases for capacity expansion at existing manufacturing facilities.
• Working Capital: Bolstering operations to support increased production and distribution.
• General Corporate Purposes: Enhancing operational infrastructure and market reach.

This targeted investment aligns with the company’s vision to scale operations and capture a larger market share. Post-listing, Medistep’s market capitalization is projected to reach Rs 61.10 crore, reflecting investor confidence in its trajectory within the essential healthcare and hygiene sectors.

The Medistep Healthcare IPO represents a pivotal moment for this agile player in India’s essential goods market. With robust recent growth, a diversified product portfolio spanning manufacturing and distribution, and clear plans for utilizing the Rs 16.09 crore in fresh capital, the company is poised for the next phase of expansion. Investors should thoroughly review the prospectus, assess the inherent risks of SME investments, and consult financial advisors before the subscription window closes on August 12, 2025.

Must Know

What is the Medistep Healthcare IPO price and lot size?
The IPO price is fixed at Rs 43 per equity share. Investors must apply in a minimum lot size of 3,000 shares, requiring an investment of Rs 129,000 per lot. The total issue size is 37,44,000 shares aiming to raise Rs 16.09 crore.

When does the Medistep IPO open and close?
The subscription window opens on Friday, August 8, 2025, and closes on Tuesday, August 12, 2025. The shares are scheduled to be listed on the NSE SME platform on Monday, August 18, 2025.

How will Medistep Healthcare use the IPO funds?
The company will allocate the net proceeds primarily towards funding capital expenditure for plant and machinery to expand its existing manufacturing facility. Funds will also support working capital requirements and general corporate purposes to fuel overall growth.

What are Medistep Healthcare’s recent financial results?
Medistep reported strong growth for FY25. Revenue surged to Rs 4965.48 lakh (up 27% from FY24’s Rs 3907.19 lakh). Profit After Tax (PAT) also rose significantly to Rs 414.42 lakh, compared to Rs 332.76 lakh in FY24, demonstrating improving profitability.

Who are the promoters and what is Medistep’s business?
Founded in 2023 and led by Managing Director Mr. Girdhari Lal Prajapati, Medistep manufactures sanitary pads and energy powder. It also trades a wide range of pharmaceutical products, nutraceuticals, intimate products, and surgical supplies through an extensive distribution network. The company acquired M/s MG Pharma in 2024 to bolster its operations.

What will be Medistep’s market cap after listing?
Based on the IPO price of Rs 43 per share and the post-issue capital, Medistep Healthcare Limited is expected to achieve a market capitalization of approximately Rs 61.10 crore upon listing on the NSE SME platform.